Search
Showing results for "1"
News & Events
Launching T1D Sports Resources (take PART)First-of-its-kind T1D sports resources have been designed to help coaches better understand the chronic condition and to encourage youth living with T1D to stay physically active.
Research
Two newly identified cat allergens: The von Ebner gland protein Fel d 7 and the latherin-like protein Fel d 8Characterization of the complete IgE binding spectrum of cat allergens is important for the development of improved diagnosis and effective immunotherapeutics.
Research
Decreasing Trends in Mean HbA1c Are Not Associated With Increasing Rates of Severe Hypoglycemia in ChildrenThere have been concurrent improvements in HbA1c and decreasing severe hypoglycemia rates in two pediatric cohorts of type 1 diabetes
News & Events
Community Involvement in the CentreCommunity Involvement and Consumer Representatives are a really important part of our research. Find out what they have been working on.
News & Events
Researcher Spotlight - David BloomDavid Bloom is a Professor of Economics and Demography at Harvard Chan School of Public Health, Global Health and Population and a Principal Investigator for our JDRF Global Centre of Excellence
News & Events
Congratulations 2024 Seed Funding Recipients!The Rio Tinto Children’s Diabetes Centre; a JDRF Global Centre of Excellence announces $60,000 in new round of seed grants for researchers dedicated to type 1 diabetes. Three researchers from across Australia have received up to $20,000 to advance their research projects in type 1 diabetes (T1D).
Research
Characteristics of Automated Insulin Suspension and Glucose Responses with the Predictive Low-Glucose Management SystemLonger suspends and fewer glycemic excursions occur at night compared with day
News & Events
Congratulations Dr Anna BoggissAnna has been awarded a three-year Fellowship to tackle the urgent gap in care in young Western Australians living with type 1 diabetes who are at heightened risk of developing eating disorders.
News & Events
Aussies publish first RCT of hybrid closed loop systemsA world-first clinical trial has shown young people with type 1 diabetes have better glycaemic control and quality of life while on hybrid closed loop (HCL) systems versus conventional treatments, Australian endocrinologists say.
Findings of a research study examining the characteristics of service use by a cohort of young people born between 1994-1997 who used four government services.